Craig-Hallum Starts Myriad Genetics (MYGN) at Buy, 'We would be buying MYGN'

February 12, 2025 7:17 AM EST Send to a Friend
(Updated - February 12, 2025 8:44 AM EST)

Craig-Hallum analyst John Wilkin initiates coverage on Myriad Genetics (NASDAQ: MYGN) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login